Want to see ANNX full AI Analyst Report?
Annexon Biosciences (ANNX) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tanruprubart | Guillain-Barre Syndrome | Phase III | Not Yet Recruiting | An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study) | Jun 06, 2025 | ― |
| Sham Administration, Anx007 | Geographic Atrophy | Phase III | Recruiting | A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA) | Jul 15, 2024 | ― |
| Anx1502 | Healthy | Phase I | Completed | Dose Study of ANX1502 in Healthy Volunteers | Aug 28, 2022 | ― |
| Anx005 | Guillain-Barre Syndrome | Phase III | Completed | Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome | Jan 06, 2021 | ― |
| Anx005 | Amyotrophic Lateral Sclerosis | Phase II | Completed | Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS) | Sep 23, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tanruprubart | Phase III | Guillain-Barre Syndrome | Not Yet Recruiting | An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study) | Jun 06, 2025 | ― |
| Sham Administration, Anx007 | Phase III | Geographic Atrophy | Recruiting | A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA) | Jul 15, 2024 | ― |
| Anx1502 | Phase I | Healthy | Completed | Dose Study of ANX1502 in Healthy Volunteers | Aug 28, 2022 | ― |
| Anx005 | Phase III | Guillain-Barre Syndrome | Completed | Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome | Jan 06, 2021 | ― |
| Anx005 | Phase II | Amyotrophic Lateral Sclerosis | Completed | Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS) | Sep 23, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Annexon Biosciences, Inc. (ANNX) have in its pipeline
Annexon Biosciences ANNX is currently developing the following drugs: Tanruprubart, Sham Administration, Anx007, Anx1502, Anx005. These drug candidates are in various stages of clinical development as the company works toward FDA approval.